Financial Year |
March 31 2023 |
Monetary Funds |
2,388,870,788.89 |
Held-for-trading Financial Assets |
785,304,178.08 |
Notes Receivable |
41,743,220.27 |
Accounts Receivable |
1,210,126,798.75 |
Advances to Suppliers |
95,246,567.59 |
Other Receivables |
65,522,357.63 |
Amounts Due From Related Companies |
-- |
Interest Receivable |
-- |
Dividend Receivable |
-- |
Inventories |
564,359,199.14 |
Among: Consumptive Biological Assets |
-- |
Non-Current Assets Maturing Within One Year |
-- |
Other Current Assets |
80,609,450.13 |
Total Current Assets |
5,251,922,543.20 |
Available-for-Sale Financial Asset |
-- |
Held-to-maturity Investments |
-- |
Long-Term Account Receivable |
-- |
Long-term Equity Investment |
84,025,356.88 |
Investment Properties |
28,222,447.13 |
Fixed Assetes |
3,556,812,775.87 |
Under-construction Projects |
592,945,501.55 |
Construction Materials |
-- |
Disposal of Fixed Assets |
-- |
Capitalized Biological Assets |
-- |
Oil and Gas Assets |
-- |
Intangible Assets |
1,679,976,321.48 |
R&D expenses |
1,229,847.88 |
Goodwill |
18,940,991.50 |
Long-Term Deferred and Prepaid Expenses |
97,084,060.12 |
Deferred Income Tax Assets |
156,778,796.86 |
Other Non-Current Assets |
322,143,093.28 |
Sub-Total of Non-Current Assets |
7,359,740,277.35 |
Total Assets |
12,611,662,820.55 |
Short-Term Loans |
1,058,664,968.08 |
Trading Financial liabilities |
926,700.00 |
Notes Payable |
46,182,119.72 |
Accounts Payable |
1,123,252,635.57 |
Accounts Received In Advance |
-- |
Employee Compensation Payable |
188,572,962.40 |
Taxes Payable |
257,933,207.02 |
Interest Payable |
-- |
Dividend Payable |
-- |
Other payables |
386,499,354.73 |
Due to Related Companies |
-- |
Non-Current Liabilities Due Within One Year |
195,849,775.45 |
Other Current Liabilities |
700,454,866.40 |
Sub-Total of Current Liabilities |
4,956,585,636.67 |
Long-term Loans |
1,347,612,845.69 |
Bonds Payable |
-- |
Long-Term Accounts Payable |
-- |
Special Payable |
-- |
Estimatied Liabilities |
-- |
Deferred Income Tax Liabilities |
24,475,996.12 |
Other Non-Current Liabilities |
-- |
Sub-Total of Non-Current Liabilities |
1,508,008,836.15 |
Total Liabilities |
6,464,594,472.82 |
Paid-In Capital(Or Share Stock) |
912,370,038.00 |
Capital Surplus |
968,149,547.04 |
Surplus Reserve |
523,449,300.26 |
LESS:Treasury Stock |
99,999,002.64 |
Undistributed Profits |
3,582,424,454.06 |
Minority Stockholder's Interest |
261,028,343.14 |
Foreign Currency Capital |
-- |
Abnormal Management Project Income Adjusted |
-- |
Total Owners' Equity Attributable to Parent(Stockholder's Interest) |
5,886,040,004.59 |
Owner's Equity(Stockholder's Equity) |
6,147,068,347.73 |
Total Liabilities and Owner's Equity(Stockholder's Equity) |
12,611,662,820.55 |